Overview of a Phase II clinical trial of isatuximab
What’s next for rare myelomas?
ENDEAVOUR, ASPIRE and TOURMALINE-MM1 trial results for multiple myeloma
Panel discussion on T-cell lymphoma: current status of therapy and progress
Elaine Jaffe et al.
Trial results and drug combinations for bortezomib in multiple myeloma